Keywords: AOM; acute otitis media; CI; confidence interval; CRM; cross-reacting material 197; DT; diphtheria toxoid; DTaP; diphtheria, tetanus, acellular pertussis; DTwP; diphtheria, tetanus, whole-cell pertussis; dPly; detoxified pneumolysin; EPA; exotoxin A of Ps
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: analytical biochemistry; biotechnology; stability; vaccines; vaccine adjuvants; excipients; AAHS; amorphous aluminum hydroxyphosphate sulfate adjuvant; AlPO4; aluminum hydroxyphosphate adjuvant; DoE; Design of Experiment; DSC; differential scanning calori
Keywords: CI; confidence interval; GLM; generalised linear model; HDU; high dependence unit; ICU; intensive care unit; IMD; invasive meningococcal disease; IRR; incidence rate ratio; JCVI; Joint Committee on Vaccination and Immunisation; LOS; length of stay; MenB;
Keywords: Meningococcal disease; Knowledge; Awareness; Survey; IMD; Invasive meningococcal disease; MenB; Meningococcal B; PBAC; Pharmaceutical Benefits Advisory Committee; SEIFA; Socio Economic Index for Areas;
Keywords: Neisseria meningitidis; Meningococcal disease; MenB vaccine; Vaccine evaluation; GNA; genome-derived Neisserial antigen; fHbp; factor H-binding protein; NadA; Neisserial adhesin A; NHBA; Neisserial heparin-binding antigen; cc; clonal complex; MenA; serogr
Keywords: AEFI; Adverse events following immunization; CCC; Complex chronic condition; CFR; Case fatality ratio; hSBA; Human serum bactericidal assay; ICER; Incremental cost-effectiveness ratio; IMD; Invasive meningococcal disease; IMPACT; Immunization Monitoring P
Individual variability in humoral response of immunized outbred mice and cross-reactivity with prevalent Brazilian Neisseria meningitidis strains
Keywords: AI; avidity index; CSF; cerebrospinal fluid; ELISA; enzyme-linked immunosorbent assay; FbpA; ferric binding protein A; FetA; ferric enterobactin A; fHbp; factor H binding protein; HLA; human leucocyte antigen; LPS; lipopolyssacharide; MenB; Neisseria meni
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults
Keywords: ACIP; Advisory Committee on Immunization Practices; EMA; European Medicines Agency; FDA; US Food and Drug Administration; FHbp; factor H binding protein; GMT; geometric mean titer; HPV; human papillomavirus; hSBA; serum bactericidal assay using human comp
Antibody persistence and booster response 68â¯months after vaccination at 2-10â¯years of age with one dose of MenACWY-TT conjugate vaccine
Keywords: AEs; adverse events; ATP; according-to-protocol; CIs; confidence intervals; GI; gastrointestinal; GMTs; geometric mean titers; hSBA; serum bactericidal activity assay using human complement; IMD; invasive meningococcal disease; M; month; MenB; meningococc
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
Site-directed mutagenesis of UbiA to promote menaquinone biosynthesis in Elizabethkingia meningoseptica
Keywords: SEPHCHC; 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic acid; DHNA; 1,4-dihydroxy-2-naphthoic acid; DMK; demethylmenaquinone; MK; menaquinone; MenF; isochorismate synthase; MenD; 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthas
Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease
Keywords: Meningococcal disease; MenB; Bexsero; Vaccine; Meningitis;
Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
Keywords: MenB; serogroup B meningococcal; fHbp; factor H binding protein; NadA; Neisseria adhesin A; NHBA; Neisseria heparin binding antigen; PorA; porin A; hSBA; serum bactericidal assay using human complement; GMC; geometric mean concentration; GMT; geometric me
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults
Keywords: IMD; invasive meningococcal disease; MenC; serogroup C meningococcal disease; MenB; serogroup B meningococcal disease; MCCV; meningococcal serogroup C conjugate vaccine; MenACWY; serogroups A, C, W, Y meningococcal disease; OMV; outer membrane vesicle; fH
Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease
Keywords: MenB; Neisseria meningitidis serogroup B; OMV; outer membrane vesicles; DOMV; detergent OMV; NOMV; native OMV; PorA; outer membrane porin A protein; LPS; lipopolysaccharide; MAT; monocyte activation test; SBA; serum bactericidal antibody; LAL; limulus ame
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
Keywords: CC; clonal complex; ELISA; enzyme-linked immunosorbent assay; fHBP; factor H binding protein; FN; false negatives; FP; false positives; HPA; Health Protection Agency; hSBA; serum bactericidal antibody assay with human complement; IMD; invasive meningococc
Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
Keywords: MCC; meningococcal serogroup C conjugate; MenB; capsular group B meningococci; QALYs; quality adjusted life years; Meningococcal; Vaccine; Model; Cost-effectiveness;
Expression of the naphthoate synthase gene in Mycobacterium tuberculosis in a self-generated oxygen depleted liquid culture system
Keywords: menB; Naphtoate synthase; Survival mechanism; Oxygen depletion; Mycobacterium tuberculosis
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: Novel antibacterial agents against Mycobacterium tuberculosis
Keywords: Mycobacterium tuberculosis; MenB; Menaquinone; 1,4-Dihydroxy-2-naphthoyl-CoA synthase; 1,4-Benzoxazine